Global Drug Repositioning Market Growth (Status and Outlook) 2022-2028
- LP 4860966
- 89 Pages
- February 2022
- Medical Devices
The United States Drug Repositioning market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drug Repositioning market, reaching US$ million by the year 2028. As for the Europe Drug Repositioning landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drug Repositioning players cover Novartis AG, Abbott Healthcare, Pfizer, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Repositioning market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Intravenous
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Central Nervous Disorders
Cardiovascular Disorders
Oncology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis AG
Abbott Healthcare
Pfizer
Johnson & Johnson
Hoffmann-La Roche
Sandoz
Mylan Inc.
Teva Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Repositioning Market Size 2017-2028
2.1.2 Drug Repositioning Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drug Repositioning Segment by Type
2.2.1 Oral
2.2.2 Intravenous
2.3 Drug Repositioning Market Size by Type
2.3.1 Drug Repositioning Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drug Repositioning Market Size Market Share by Type (2017-2022)
2.4 Drug Repositioning Segment by Application
2.4.1 Central Nervous Disorders
2.4.2 Cardiovascular Disorders
2.4.3 Oncology
2.4.4 Others
2.5 Drug Repositioning Market Size by Application
2.5.1 Drug Repositioning Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drug Repositioning Market Size Market Share by Application (2017-2022)
3 Drug Repositioning Market Size by Player
3.1 Drug Repositioning Market Size Market Share by Players
3.1.1 Global Drug Repositioning Revenue by Players (2020-2022)
3.1.2 Global Drug Repositioning Revenue Market Share by Players (2020-2022)
3.2 Global Drug Repositioning Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Repositioning by Regions
4.1 Drug Repositioning Market Size by Regions (2017-2022)
4.2 Americas Drug Repositioning Market Size Growth (2017-2022)
4.3 APAC Drug Repositioning Market Size Growth (2017-2022)
4.4 Europe Drug Repositioning Market Size Growth (2017-2022)
4.5 Middle East & Africa Drug Repositioning Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drug Repositioning Market Size by Country (2017-2022)
5.2 Americas Drug Repositioning Market Size by Type (2017-2022)
5.3 Americas Drug Repositioning Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Repositioning Market Size by Region (2017-2022)
6.2 APAC Drug Repositioning Market Size by Type (2017-2022)
6.3 APAC Drug Repositioning Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Repositioning by Country (2017-2022)
7.2 Europe Drug Repositioning Market Size by Type (2017-2022)
7.3 Europe Drug Repositioning Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Repositioning by Region (2017-2022)
8.2 Middle East & Africa Drug Repositioning Market Size by Type (2017-2022)
8.3 Middle East & Africa Drug Repositioning Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Repositioning Market Forecast
10.1 Global Drug Repositioning Forecast by Regions (2023-2028)
10.1.1 Global Drug Repositioning Forecast by Regions (2023-2028)
10.1.2 Americas Drug Repositioning Forecast
10.1.3 APAC Drug Repositioning Forecast
10.1.4 Europe Drug Repositioning Forecast
10.1.5 Middle East & Africa Drug Repositioning Forecast
10.2 Americas Drug Repositioning Forecast by Country (2023-2028)
10.2.1 United States Drug Repositioning Market Forecast
10.2.2 Canada Drug Repositioning Market Forecast
10.2.3 Mexico Drug Repositioning Market Forecast
10.2.4 Brazil Drug Repositioning Market Forecast
10.3 APAC Drug Repositioning Forecast by Region (2023-2028)
10.3.1 China Drug Repositioning Market Forecast
10.3.2 Japan Drug Repositioning Market Forecast
10.3.3 Korea Drug Repositioning Market Forecast
10.3.4 Southeast Asia Drug Repositioning Market Forecast
10.3.5 India Drug Repositioning Market Forecast
10.3.6 Australia Drug Repositioning Market Forecast
10.4 Europe Drug Repositioning Forecast by Country (2023-2028)
10.4.1 Germany Drug Repositioning Market Forecast
10.4.2 France Drug Repositioning Market Forecast
10.4.3 UK Drug Repositioning Market Forecast
10.4.4 Italy Drug Repositioning Market Forecast
10.4.5 Russia Drug Repositioning Market Forecast
10.5 Middle East & Africa Drug Repositioning Forecast by Region (2023-2028)
10.5.1 Egypt Drug Repositioning Market Forecast
10.5.2 South Africa Drug Repositioning Market Forecast
10.5.3 Israel Drug Repositioning Market Forecast
10.5.4 Turkey Drug Repositioning Market Forecast
10.5.5 GCC Countries Drug Repositioning Market Forecast
10.6 Global Drug Repositioning Forecast by Type (2023-2028)
10.7 Global Drug Repositioning Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis AG
11.1.1 Novartis AG Company Information
11.1.2 Novartis AG Drug Repositioning Product Offered
11.1.3 Novartis AG Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis AG Main Business Overview
11.1.5 Novartis AG Latest Developments
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Information
11.2.2 Abbott Healthcare Drug Repositioning Product Offered
11.2.3 Abbott Healthcare Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbott Healthcare Main Business Overview
11.2.5 Abbott Healthcare Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Drug Repositioning Product Offered
11.3.3 Pfizer Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Drug Repositioning Product Offered
11.4.3 Johnson & Johnson Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Hoffmann-La Roche
11.5.1 Hoffmann-La Roche Company Information
11.5.2 Hoffmann-La Roche Drug Repositioning Product Offered
11.5.3 Hoffmann-La Roche Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Hoffmann-La Roche Main Business Overview
11.5.5 Hoffmann-La Roche Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Drug Repositioning Product Offered
11.6.3 Sandoz Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Mylan Inc.
11.7.1 Mylan Inc. Company Information
11.7.2 Mylan Inc. Drug Repositioning Product Offered
11.7.3 Mylan Inc. Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mylan Inc. Main Business Overview
11.7.5 Mylan Inc. Latest Developments
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Information
11.8.2 Teva Pharmaceuticals Drug Repositioning Product Offered
11.8.3 Teva Pharmaceuticals Drug Repositioning Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Teva Pharmaceuticals Main Business Overview
11.8.5 Teva Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Drug Repositioning Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Intravenous
Table 4. Drug Repositioning Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drug Repositioning Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drug Repositioning Market Size Market Share by Type (2017-2022)
Table 7. Drug Repositioning Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drug Repositioning Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drug Repositioning Market Size Market Share by Application (2017-2022)
Table 10. Global Drug Repositioning Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drug Repositioning Revenue Market Share by Player (2020-2022)
Table 12. Drug Repositioning Key Players Head office and Products Offered
Table 13. Drug Repositioning Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drug Repositioning Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drug Repositioning Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drug Repositioning Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drug Repositioning Market Size Market Share by Country (2017-2022)
Table 20. Americas Drug Repositioning Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drug Repositioning Market Size Market Share by Type (2017-2022)
Table 22. Americas Drug Repositioning Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drug Repositioning Market Size Market Share by Application (2017-2022)
Table 24. APAC Drug Repositioning Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drug Repositioning Market Size Market Share by Region (2017-2022)
Table 26. APAC Drug Repositioning Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drug Repositioning Market Size Market Share by Type (2017-2022)
Table 28. APAC Drug Repositioning Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drug Repositioning Market Size Market Share by Application (2017-2022)
Table 30. Europe Drug Repositioning Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drug Repositioning Market Size Market Share by Country (2017-2022)
Table 32. Europe Drug Repositioning Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drug Repositioning Market Size Market Share by Type (2017-2022)
Table 34. Europe Drug Repositioning Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drug Repositioning Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drug Repositioning Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drug Repositioning Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drug Repositioning Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drug Repositioning Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drug Repositioning Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drug Repositioning Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drug Repositioning
Table 43. Key Market Challenges & Risks of Drug Repositioning
Table 44. Key Industry Trends of Drug Repositioning
Table 45. Global Drug Repositioning Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drug Repositioning Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drug Repositioning Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drug Repositioning Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drug Repositioning Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drug Repositioning Market Size Market Share Forecast by Application (2023-2028)
Table 51. Novartis AG Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 52. Novartis AG Drug Repositioning Product Offered
Table 53. Novartis AG Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Novartis AG Main Business
Table 55. Novartis AG Latest Developments
Table 56. Abbott Healthcare Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 57. Abbott Healthcare Drug Repositioning Product Offered
Table 58. Abbott Healthcare Main Business
Table 59. Abbott Healthcare Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Abbott Healthcare Latest Developments
Table 61. Pfizer Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 62. Pfizer Drug Repositioning Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Pfizer Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 67. Johnson & Johnson Drug Repositioning Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson & Johnson Latest Developments
Table 71. Hoffmann-La Roche Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 72. Hoffmann-La Roche Drug Repositioning Product Offered
Table 73. Hoffmann-La Roche Main Business
Table 74. Hoffmann-La Roche Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Hoffmann-La Roche Latest Developments
Table 76. Sandoz Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 77. Sandoz Drug Repositioning Product Offered
Table 78. Sandoz Main Business
Table 79. Sandoz Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Sandoz Latest Developments
Table 81. Mylan Inc. Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 82. Mylan Inc. Drug Repositioning Product Offered
Table 83. Mylan Inc. Main Business
Table 84. Mylan Inc. Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mylan Inc. Latest Developments
Table 86. Teva Pharmaceuticals Details, Company Type, Drug Repositioning Area Served and Its Competitors
Table 87. Teva Pharmaceuticals Drug Repositioning Product Offered
Table 88. Teva Pharmaceuticals Main Business
Table 89. Teva Pharmaceuticals Drug Repositioning Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Teva Pharmaceuticals Latest Developments
List of Figures
Figure 1. Drug Repositioning Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug Repositioning Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drug Repositioning Market Size Market Share by Type in 2021
Figure 7. Drug Repositioning in Central Nervous Disorders
Figure 8. Global Drug Repositioning Market: Central Nervous Disorders (2017-2022) & ($ Millions)
Figure 9. Drug Repositioning in Cardiovascular Disorders
Figure 10. Global Drug Repositioning Market: Cardiovascular Disorders (2017-2022) & ($ Millions)
Figure 11. Drug Repositioning in Oncology
Figure 12. Global Drug Repositioning Market: Oncology (2017-2022) & ($ Millions)
Figure 13. Drug Repositioning in Others
Figure 14. Global Drug Repositioning Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Drug Repositioning Market Size Market Share by Application in 2021
Figure 16. Global Drug Repositioning Revenue Market Share by Player in 2021
Figure 17. Global Drug Repositioning Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Drug Repositioning Market Size 2017-2022 ($ Millions)
Figure 19. APAC Drug Repositioning Market Size 2017-2022 ($ Millions)
Figure 20. Europe Drug Repositioning Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Drug Repositioning Market Size 2017-2022 ($ Millions)
Figure 22. Americas Drug Repositioning Value Market Share by Country in 2021
Figure 23. Americas Drug Repositioning Consumption Market Share by Type in 2021
Figure 24. Americas Drug Repositioning Market Size Market Share by Application in 2021
Figure 25. United States Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Drug Repositioning Market Size Market Share by Region in 2021
Figure 30. APAC Drug Repositioning Market Size Market Share by Application in 2021
Figure 31. China Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Drug Repositioning Market Size Market Share by Country in 2021
Figure 38. Europe Drug Repositioning Market Size Market Share by Type in 2021
Figure 39. Europe Drug Repositioning Market Size Market Share by Application in 2021
Figure 40. Germany Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Drug Repositioning Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Drug Repositioning Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Drug Repositioning Market Size Market Share by Application in 2021
Figure 48. Egypt Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Drug Repositioning Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 54. APAC Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 55. Europe Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 57. United States Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 58. Canada Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 61. China Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 62. Japan Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 63. Korea Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 65. India Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 66. Australia Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 67. Germany Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 68. France Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 69. UK Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 70. Italy Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 71. Russia Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 72. Spain Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 75. Israel Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Drug Repositioning Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Drug Repositioning Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
